All filters
Slidesets
Integrated Decentralized Guidelines for Care – WHO Guidelines - Philippa Easterbrook, MD, FRCP, MPH, DTM&H
Presented at:
Conference on Liver Disease in Africa (COLDA) 2022
Slidesets
Modelling Elimination Strategies in Africa - Shevanthi Nayagam, MBBS, MRCP, PhD
Presented at:
Conference on Liver Disease in Africa (COLDA) 2022
Slidesets
Vertical Transmission, Maternal Care, and Family Care - Manal El-Sayed, MD, PhD
Presented at:
Conference on Liver Disease in Africa (COLDA) 2022
Slidesets
Blood Safety & Surveillance - Yuyun S. Maryuningsih, MD, PhD
Presented at:
Conference on Liver Disease in Africa (COLDA) 2022
Slidesets
From Pandemic Response to Pandemic Recovery - Opportunities for Viral Hepatitis Elimination - John Ward, MD
Presented at:
Conference on Liver Disease in Africa (COLDA) 2022
Slidesets
Call for Action - “Call for Action - “We Need Testing and Treatment - NOW” - Bisi Bright, B.Pharm(Hons), MPH, FPCPharm, FPSN, C.Psych
Presented at:
Conference on Liver Disease in Africa (COLDA) 2022
Slidesets
Call for Action - “We Need Solutions” - Agnes Binagwaho, MD, M(Ped), PhD
Presented at:
Conference on Liver Disease in Africa (COLDA) 2022
Slidesets
Call for Action - “We Need (HQ) Data - To Plan Services” - Olufunmilayo Lesi, MD, MBA, FMCP
Presented at:
Conference on Liver Disease in Africa (COLDA) 2022
Slidesets
Call for Action - “We Need to Address the Challenges - Now” - The South African Experience - Wendy Spearman, MBChB, FCP, FRCP, MMed, PhD
Presented at:
Conference on Liver Disease in Africa (COLDA) 2022
Slidesets
Implementing LA-ARVs in Europe: Which Patient? Which Formulation?
Presented at:
European Meeting on HIV & Hepatitis 2022
Slidesets
Implementing LA-ARVs in Europe: Which Patient? Which Formulation?
Presented at:
European Meeting on HIV & Hepatitis 2022
Slidesets
HIV Transmission Clusters in Europe: A Perspective View of Late Presenters and Non-Late Presenters
Presented at:
European Meeting on HIV & Hepatitis 2022
Slidesets
Transmitted Drug Resistance to Integrase Based First-Line Treatment in Europe, 2018-2021
Presented at:
European Meeting on HIV & Hepatitis 2022
Slidesets
New Antiretroviral Compounds: What Are the Resistance Concerns?
Presented at:
European Meeting on HIV & Hepatitis 2022
Slidesets
New Antiretroviral Compounds: What Are the Resistance Concerns?
Presented at:
European Meeting on HIV & Hepatitis 2022
Slidesets
The Top 10 Important Observations Last Year
Presented at:
European Meeting on HIV & Hepatitis 2022
Slidesets
Country Experiences: Southern Europe / Italy
Presented at:
European Meeting on HIV & Hepatitis 2022
Slidesets
Country Experiences: Northern Europe / Sweden
Presented at:
European Meeting on HIV & Hepatitis 2022
Slidesets
Country Experiences: Eastern Europe / Czech Republic
Presented at:
European Meeting on HIV & Hepatitis 2022
Slidesets
Country Experiences: Western Europe / France
Presented at:
European Meeting on HIV & Hepatitis 2022
Slidesets
Levels and Durability of Humoral and T-Specific Responses After the Booster Dose of mRNA BNT162b2 Vaccine in Residents of a Long Term Care Facility
Presented at:
European Meeting on HIV & Hepatitis 2022
Slidesets
Impact of Sars-Cov-2 Omicron and Delta Sub-Lineage AY.4.2 Variant on Neutralization by Sera of Patients Treated With Different Licensed Monoclonal Antibodies
Presented at:
European Meeting on HIV & Hepatitis 2022
Slidesets
Circulation of SARS-CoV-2 Variants in Central Italy: Spike Variability Characterization by Deep-Sequencing (#2)
Presented at:
European Meeting on HIV & Hepatitis 2022